Myocardial infarction risk and the clinical significance of metabolic syndrome in the absence of hypertension and diabetes: Insights from a large cohort screening population.

Masrouri S, Ebrahimi N, Zooravar D, Shapiro MD, Azizi F, Hadaegh F

AJPC academy: A four-pillar model for cultivating the next generation of academic leaders in cardiovascular prevention.

Vergara Sanchez C, Dudum R, Shapiro MD, Nasir K

A shared responsibility for the future of prevention - Aligning ASPC and AJPC.

Shapiro MD

Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems.

Shah NP, Peterson ED, Shrader P, Shoji S, Freeman N, Martin SS, Allred C, Fernandez S, Chamberlain AM, Arnold J, Shapiro MD, Effron MB, Priest E, Syed M, Kirchner HL, Leja M, Ahmad Z, Kalich B, Jin R, Jones LK, Wojcik C, Navar AM

Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank.

Kazibwe R, Schaich CL, Chevli PA, Kingsley JA, Mirzai S, Namutebi JH, Imtiaz Ahmad M, Mehta A, Bhatia HS, Paukner M, Rikhi R, Michos ED, Shapiro MD

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.

Baldassarre LA, Mendes LA, Blankstein R, Hahn RT, Patel AR, Russell R, Abbara S, Ahmad SM, Brady MB, Bullock-Palmer RP, Cavalcante JL, Chareonthaitawee P, Chen T, Clark DE, Conaway DG, Daubert MA, Day J, Di Carli MF, Galazka P, Gallegos-Kattán C, Herrmann H, Ho EC, Jellis CL, Le VT, Lema PC, Litmanovich DE, Little SH, Liu JE, Lopez-Mattei JC, Lumsden AB, Malaisrie SC, Melduni RM, Nieman K, Nikravan S, Ordovas KG, Parwani P, Patel KK, Phoubandith DR, Punnoose LR, Rybicki FJ, Sensakovic WF, Shapiro MD, Sperry BW, Spragg D, Tong MS, Vogel-Bass E, Volgman AS, Waheed A, Weissman G, Wells BJ

Integrating ketone bodies in multi-marker risk prediction of incident heart failure in the multi-ethnic study of atherosclerosis.

Chevli PA, Selvaraj S, Jaeger BC, Hammoud A, Connelly MA, deFilippi C, Lima JAC, Khan SS, Herrington DM, Shapiro MD, Vaduganathan M

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.

Zhou XD, Lian LY, Chen QF, Kim SU, Cheuk-Fung Yip T, Petta S, Nakajima A, Tsochatzis E, Shi J, Chan WK, Boursier J, Bugianesi E, Yilmaz Y, Hagström H, Romero-Gomez M, Alswat K, Calleja JL, Takahashi H, de Lédinghen V, Shalimar, Castéra L, Sanyal AJ, Goh GB, Newsome PN, Fan JG, Lai M, Aggarwal S, Kechagias S, Hiasa Y, Dayal B, Zhang Z, George J, El-Kassas M, Chen J, You H, Abu Dayyeh BK, Sheng H, Adams LA, Wang J, He F, Liang H, Yang YF, Chi X, Zhong B, Bi Y, Mi Y, Zhu Y, Bai R, Zhang J, Wang B, Song J, Deng H, Xie Q, Bai L, Xin Y, Xie W, Li J, Fournier-Poizat C, Zoncapè M, Xia T, Ju S, Wu C, Lee HW, Wong GL, Armandi A, Shang Y, Pennisi G, Llop E, Yoneda M, de Saint-Loup M, Canivet CM, Lara-Romero C, Gallego-Durán R, Carrillo-Fernández P, Asgharpour A, Teh KK, Mahgoub S, Chan MS, Lin H, Liu WY, Song SJ, Al-Hamoudi WK, Isoda H, Miyake T, Satapathy SK, Li M, Sharma K, Emadeldeen M, Zhou L, Tong X, Bazerbachi F, Fan X, Xiao H, Ye J, Xu L, Wang X, Targher G, Byrne CD, Shapiro MD, Tacke F, Wai-Sun Wong V, Zheng MH, VCTE-Prognosis Study Group, Paired Liver Biopsy Group

Modeling Benefit of Aspirin According to Lp(a) and Coronary Artery Calcium: MESA.

Razavi AC, Dzaye O, Bhatia HS, Vaccarino V, Mehta A, Rotter JI, Guo X, Taylor KD, Yao J, Li X, Rich SS, Budoff MJ, Tsai MY, Blankstein R, Shapiro MD, Nasir K, Tsimikas S, Blumenthal RS, Whelton SP, Blaha MJ, Sperling LS

Prevalence of Apolipoprotein B and LDL Cholesterol Discordance: Insights From the VLDbL and NHANES.

Peng AW, Gianos E, Shapiro MD, Navar AM, Zahid S, Marvel FA, Blaha MJ, Rodriguez F, Soffer DE, Morris PB, Blumenthal RS, Martin SS